HU190445B - Process for producing salicylic acid-derivatives and pharmaceutical compositions containing the same - Google Patents
Process for producing salicylic acid-derivatives and pharmaceutical compositions containing the same Download PDFInfo
- Publication number
- HU190445B HU190445B HU831092A HU109283A HU190445B HU 190445 B HU190445 B HU 190445B HU 831092 A HU831092 A HU 831092A HU 109283 A HU109283 A HU 109283A HU 190445 B HU190445 B HU 190445B
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- compound
- acid
- carboxylic acid
- ethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Quinoline Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823211934 DE3211934A1 (de) | 1982-03-31 | 1982-03-31 | Salicylsaeurederivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU190445B true HU190445B (en) | 1986-09-29 |
Family
ID=6159858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU831092A HU190445B (en) | 1982-03-31 | 1983-03-30 | Process for producing salicylic acid-derivatives and pharmaceutical compositions containing the same |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4542127A (Sortimente) |
| EP (1) | EP0090369B1 (Sortimente) |
| JP (1) | JPS58177974A (Sortimente) |
| KR (1) | KR840004080A (Sortimente) |
| AT (1) | ATE17350T1 (Sortimente) |
| AU (1) | AU1300383A (Sortimente) |
| CA (1) | CA1197240A (Sortimente) |
| DE (2) | DE3211934A1 (Sortimente) |
| DK (1) | DK149383A (Sortimente) |
| ES (1) | ES8401944A1 (Sortimente) |
| FI (1) | FI831070A7 (Sortimente) |
| GR (1) | GR79241B (Sortimente) |
| HU (1) | HU190445B (Sortimente) |
| MA (1) | MA19764A1 (Sortimente) |
| NO (1) | NO831170L (Sortimente) |
| NZ (1) | NZ203743A (Sortimente) |
| PT (1) | PT76473B (Sortimente) |
| ZA (1) | ZA832292B (Sortimente) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5312924A (en) | 1983-12-30 | 1994-05-17 | Dr. Karl Thomae Gmbh | Phenylacetic acid benzylamides |
| US5216167A (en) * | 1983-12-30 | 1993-06-01 | Dr. Karl Thomae Gmbh | Phenylacetic acid benzylamides |
| US6924251B1 (en) | 1998-07-24 | 2005-08-02 | Bayer Aktiengesellschaft | Substituted benzoylcyclohexandiones |
| DE19920791A1 (de) | 1999-05-06 | 2000-11-09 | Bayer Ag | Substituierte Benzoylisoxazole |
| DE19921424A1 (de) | 1999-05-08 | 2000-11-09 | Bayer Ag | Substituierte Benzoylketone |
| DE19946853A1 (de) | 1999-09-30 | 2001-04-05 | Bayer Ag | Substituierte Arylketone |
| US7985743B1 (en) * | 2005-07-22 | 2011-07-26 | Gene A. Tabish | Topical pain reliever and method of making the same |
| WO2012025239A1 (en) | 2010-08-27 | 2012-03-01 | Grünenthal GmbH | Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as kcnq2/3 modulators |
| MX2013002121A (es) | 2010-08-27 | 2013-04-03 | Gruenenthal Gmbh | Quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3. |
| DK2609083T3 (da) | 2010-08-27 | 2015-03-30 | Gruenenthal Gmbh | Substituerede 2-oxy-quinolin-3-carboxamider som KCNQ2/3 modulatorer |
| WO2012025237A1 (en) | 2010-08-27 | 2012-03-01 | Grünenthal GmbH | Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators |
| MX2013002295A (es) | 2010-09-01 | 2013-05-09 | Gruenenthal Gmbh | 1-oxo-dihidroisoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3. |
| KR20250006217A (ko) * | 2022-04-25 | 2025-01-10 | 사이트원 테라퓨틱스, 인코포레이티드 | 통증 치료를 위한 Naν1.8의 바이사이클릭 헤테로사이클릭 아미드 억제제 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1185180B (de) * | 1963-10-19 | 1965-01-14 | Hoechst Ag | Verfahren zur Herstellung von Benzolsulfonylharnstoffen |
| DE2500157C2 (de) * | 1975-01-03 | 1983-09-15 | Hoechst Ag, 6230 Frankfurt | N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung |
| DE2706977A1 (de) * | 1977-02-18 | 1978-08-24 | Hoechst Ag | Benzoesaeuren und deren derivate sowie verfahren zu ihrer herstellung |
| EP0023569B1 (de) * | 1979-07-13 | 1983-06-22 | Dr. Karl Thomae GmbH | Carbonsäure-Derivate, deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE3100535A1 (de) * | 1981-01-10 | 1982-08-12 | Dr. Karl Thomae Gmbh, 7950 Biberach | "neue carbonsaeure-derivate, ihre herstellung und ihre verwendung als arzneimittel" |
-
1982
- 1982-03-31 DE DE19823211934 patent/DE3211934A1/de not_active Withdrawn
-
1983
- 1983-03-21 KR KR1019830001272A patent/KR840004080A/ko not_active Withdrawn
- 1983-03-25 EP EP83102983A patent/EP0090369B1/de not_active Expired
- 1983-03-25 DE DE8383102983T patent/DE3361757D1/de not_active Expired
- 1983-03-25 AT AT83102983T patent/ATE17350T1/de not_active IP Right Cessation
- 1983-03-29 FI FI831070A patent/FI831070A7/fi not_active Application Discontinuation
- 1983-03-29 GR GR70927A patent/GR79241B/el unknown
- 1983-03-29 US US06/479,906 patent/US4542127A/en not_active Expired - Fee Related
- 1983-03-29 NO NO831170A patent/NO831170L/no unknown
- 1983-03-29 NZ NZ203743A patent/NZ203743A/en unknown
- 1983-03-29 PT PT76473A patent/PT76473B/pt unknown
- 1983-03-29 ES ES521082A patent/ES8401944A1/es not_active Expired
- 1983-03-30 HU HU831092A patent/HU190445B/hu unknown
- 1983-03-30 AU AU13003/83A patent/AU1300383A/en not_active Abandoned
- 1983-03-30 DK DK149383A patent/DK149383A/da not_active IP Right Cessation
- 1983-03-30 CA CA000424930A patent/CA1197240A/en not_active Expired
- 1983-03-30 JP JP58052808A patent/JPS58177974A/ja active Pending
- 1983-03-30 ZA ZA832292A patent/ZA832292B/xx unknown
- 1983-03-31 MA MA19984A patent/MA19764A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU1300383A (en) | 1983-10-06 |
| PT76473A (de) | 1983-04-01 |
| EP0090369B1 (de) | 1986-01-08 |
| DE3361757D1 (en) | 1986-02-20 |
| KR840004080A (ko) | 1984-10-06 |
| FI831070A0 (fi) | 1983-03-29 |
| JPS58177974A (ja) | 1983-10-18 |
| MA19764A1 (fr) | 1983-10-01 |
| CA1197240A (en) | 1985-11-26 |
| FI831070L (fi) | 1983-10-01 |
| DK149383D0 (da) | 1983-03-30 |
| NZ203743A (en) | 1985-07-12 |
| PT76473B (de) | 1986-01-24 |
| US4542127A (en) | 1985-09-17 |
| FI831070A7 (fi) | 1983-10-01 |
| ES521082A0 (es) | 1984-01-01 |
| DK149383A (da) | 1983-10-01 |
| GR79241B (Sortimente) | 1984-10-22 |
| ATE17350T1 (de) | 1986-01-15 |
| ES8401944A1 (es) | 1984-01-01 |
| NO831170L (no) | 1983-10-03 |
| DE3211934A1 (de) | 1983-10-13 |
| ZA832292B (en) | 1983-12-28 |
| EP0090369A1 (de) | 1983-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4193926A (en) | 4-(Polyalkoxy phenyl)-2-pyrrolidones | |
| DE69431462T2 (de) | Glycoprotein IIb/IIIa Antagonisten | |
| KR20010105394A (ko) | 디아릴 유도체 및 그의 의약으로서의 용도 | |
| KR20060114376A (ko) | 식욕 감퇴 화합물 | |
| CS228506B2 (en) | Method for the production of optical active ester of 1,4-dihydropyridincarboxyl acid | |
| WO1996022288A1 (en) | GLYCOPROTEIN IIb/IIIa ANTAGONISTS | |
| HU190445B (en) | Process for producing salicylic acid-derivatives and pharmaceutical compositions containing the same | |
| NO165192B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater. | |
| JPH0673038A (ja) | ビフェニル誘導体、これらの化合物を含む医薬組成物及びそれらの調製法 | |
| JPH0730028B2 (ja) | アシル−コエンチームａ：コレステロールアシルトランスフェラーゼの抑制剤としてのｎ−アシル−テトラヒドロイソキノリン類 | |
| DE69824450T2 (de) | Biphenylamidin-derivate | |
| EP0974583B1 (en) | Phenylpiperidine derivatives | |
| US4097481A (en) | Tertiary amide derivatives of pyrrolidine and piperidine | |
| US6300337B1 (en) | Acetamide derivative and use thereof | |
| US4166117A (en) | 1-(Aralkyl)-4-(4-oxo[3H]quinazolin-3-yl)piperidines | |
| US4814345A (en) | 1-phenyl-2-aminocarbonylindole compounds, preparation thereof and pharmaceutical compositions containing them | |
| US4243666A (en) | 4-Amino-2-piperidino-quinazolines | |
| JP3158638B2 (ja) | 新規アミノフェノール誘導体及びその医薬用途 | |
| KR20100081349A (ko) | 브라디키닌 ｂ１ 길항제인 신규 비펩티드 유도체 | |
| US4758559A (en) | Pyrrolo[1,2-a] [4,1]benzoxazepine derivatives useful as calmodulin and histamine inhibitors | |
| LT3798B (en) | Method for the preparation of n,n'-bis(alkoxyalkyl)-pyrimidine-2,4-dicarboxylic acids diamides and use thereof | |
| EP0433064A1 (en) | Naphthylsulfonylalkanoic acid compounds | |
| JPH0372623B2 (Sortimente) | ||
| US5714501A (en) | Piperidine derivatives | |
| EP0662965A1 (en) | 1,2-disubstituted ethyl amides as inhibitors of acat |